Stockholm-based Elekta secures €100 million EIB loan to advance cancer and neurological treatments | EU-Startups
Summary
Elekta secured up to €100 million in loan financing from the European Investment Bank to support its next research program. The company plans to use the funds for work on cancer and neurological treatments between 2026 and 2029. Elekta will focus on radiotherapy, radiosurgery, brachytherapy, and the software platforms that plan and deliver these therapies. The financing gives Elekta more flexibility to invest in clinical outcomes, operational efficiency, and patient experience.
Funding
Amount
-
Total raised
Date
August 31, 2026
Announcement date
Investors
European Investment Bank
Lead investors
Company
elekta.com
Funded company
AskAI Classifications
Sectors
HealthTech
General Healthcare software
Medical Imaging Software
Functions
No functions detected
